These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 25262156)

  • 1. Expression of extracellular domains of muscle specific kinase (MuSK) and use as immunoadsorbents for the development of an antigen-specific therapy.
    Skriapa L; Zisimopoulou P; Trakas N; Grapsa E; Tzartos SJ
    J Neuroimmunol; 2014 Nov; 276(1-2):150-8. PubMed ID: 25262156
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-MuSK myasthenia gravis presenting with purely ocular findings.
    Caress JB; Hunt CH; Batish SD
    Arch Neurol; 2005 Jun; 62(6):1002-3. PubMed ID: 15956173
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Auto-antibodies to the receptor tyrosine kinase MuSK in patients with myasthenia gravis without acetylcholine receptor antibodies.
    Hoch W; McConville J; Helms S; Newsom-Davis J; Melms A; Vincent A
    Nat Med; 2001 Mar; 7(3):365-8. PubMed ID: 11231638
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-MuSK antibody myasthenia gravis: clinical findings and response to treatment in two large cohorts.
    Guptill JT; Sanders DB; Evoli A
    Muscle Nerve; 2011 Jul; 44(1):36-40. PubMed ID: 21674519
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Passive transfer models of myasthenia gravis with muscle-specific kinase antibodies.
    Verschuuren JJGM; Plomp JJ; Burden SJ; Zhang W; Fillié-Grijpma YE; Stienstra-van Es IE; Niks EH; Losen M; van der Maarel SM; Huijbers MG
    Ann N Y Acad Sci; 2018 Feb; 1413(1):111-118. PubMed ID: 29356029
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pathogenic IgG4 subclass autoantibodies in MuSK myasthenia gravis.
    Plomp JJ; Huijbers MG; van der Maarel SM; Verschuuren JJ
    Ann N Y Acad Sci; 2012 Dec; 1275():114-22. PubMed ID: 23278586
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of a highly sensitive diagnostic assay for muscle-specific tyrosine kinase (MuSK) autoantibodies in myasthenia gravis.
    Trakas N; Zisimopoulou P; Tzartos SJ
    J Neuroimmunol; 2011 Dec; 240-241():79-86. PubMed ID: 21993075
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MuSK antibody positive myasthenia gravis plasma modifies MURF-1 expression in C2C12 cultures and mouse muscle in vivo.
    Benveniste O; Jacobson L; Farrugia ME; Clover L; Vincent A
    J Neuroimmunol; 2005 Dec; 170(1-2):41-8. PubMed ID: 16213598
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antigen-specific apheresis of autoantibodies in myasthenia gravis.
    Lazaridis K; Zisimopoulou P; Lagoumintzis G; Skriapa L; Trakas N; Evangelakou P; Kanelopoulos I; Grapsa E; Poulas K; Tzartos S
    Ann N Y Acad Sci; 2012 Dec; 1275():7-12. PubMed ID: 23278571
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Myasthenia gravis induced by autoantibodies against MuSK].
    Shigemoto K; Konishi T; Ohta M
    Nihon Rinsho; 2008 Jun; 66(6):1149-54. PubMed ID: 18540361
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Extracellular domains of the beta, gamma and epsilon subunits of the human acetylcholine receptor as immunoadsorbents for myasthenic autoantibodies: a combination of immunoadsorbents results in increased efficiency.
    Kostelidou K; Trakas N; Tzartos SJ
    J Neuroimmunol; 2007 Oct; 190(1-2):44-52. PubMed ID: 17764755
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MuSK autoantibodies in myasthenia gravis detected by cell based assay--A multinational study.
    Tsonis AI; Zisimopoulou P; Lazaridis K; Tzartos J; Matsigkou E; Zouvelou V; Mantegazza R; Antozzi C; Andreetta F; Evoli A; Deymeer F; Saruhan-Direskeneli G; Durmus H; Brenner T; Vaknin A; Berrih-Aknin S; Behin A; Sharshar T; De Baets M; Losen M; Martinez-Martinez P; Kleopa KA; Zamba-Papanicolaou E; Kyriakides T; Kostera-Pruszczyk A; Szczudlik P; Szyluk B; Lavrnic D; Basta I; Peric S; Tallaksen C; Maniaol A; Casasnovas Pons C; Pitha J; Jakubíkova M; Hanisch F; Tzartos SJ
    J Neuroimmunol; 2015 Jul; 284():10-7. PubMed ID: 26025053
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Myasthenia gravis patients with anti-MuSK antibodies.
    Zagar M; Vranjes D; Sostarko M; Vogrinc Z; Bilić E; Trbojević Cepe M
    Coll Antropol; 2009 Dec; 33(4):1151-4. PubMed ID: 20102061
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antigen-specific apheresis of pathogenic autoantibodies from myasthenia gravis sera.
    Tzartos SJ; Bitzopoulou K; Gavra I; Kordas G; Jacobson L; Kostelidou K; Lagoumintzis G; Lazos O; Poulas K; Sideris S; Sotiriadis A; Trakas N; Zisimopoulou P
    Ann N Y Acad Sci; 2008; 1132():291-9. PubMed ID: 18567880
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-MuSK patient antibodies disrupt the mouse neuromuscular junction.
    Cole RN; Reddel SW; Gervásio OL; Phillips WD
    Ann Neurol; 2008 Jun; 63(6):782-9. PubMed ID: 18384168
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Myasthenia gravis experimentally induced with muscle-specific kinase.
    Shigemoto K; Kubo S; Jie C; Hato N; Abe Y; Ueda N; Kobayashi N; Kameda K; Mominoki K; Miyazawa A; Ishigami A; Matsuda S; Maruyama N
    Ann N Y Acad Sci; 2008; 1132():93-8. PubMed ID: 18096854
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Longitudinal epitope mapping in MuSK myasthenia gravis: implications for disease severity.
    Huijbers MG; Vink AF; Niks EH; Westhuis RH; van Zwet EW; de Meel RH; Rojas-García R; Díaz-Manera J; Kuks JB; Klooster R; Straasheijm K; Evoli A; Illa I; van der Maarel SM; Verschuuren JJ
    J Neuroimmunol; 2016 Feb; 291():82-8. PubMed ID: 26857500
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-agrin autoantibodies in myasthenia gravis.
    Gasperi C; Melms A; Schoser B; Zhang Y; Meltoranta J; Risson V; Schaeffer L; Schalke B; Kröger S
    Neurology; 2014 Jun; 82(22):1976-83. PubMed ID: 24793185
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Pathogenic mechanisms of myasthenia gravis induced by antibodies against muscle-specific kinase].
    Maruyama N; Shigemoto K
    Rinsho Shinkeigaku; 2007 Nov; 47(11):842-4. PubMed ID: 18210813
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-MuSK myasthenia gravis presenting with Epstein-Barr virus-associated mononucleosis and immune-mediated diabetes mellitus.
    Bhibhatbhan A; Kline G; Vincent A; Toth C
    Muscle Nerve; 2007 Aug; 36(2):264-6. PubMed ID: 17266132
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.